Clinical Trials Logo

Clinical Trial Summary

The goal of this observational clinical trial is to compare assessment reagents with clinical diagnostic criteria in patients with membranous nephropathy. The main questions it aims to answer are: - Evaluating the sensitivity and specificity of the test reagent in the diagnosis of membranous nephropathy. - Evaluating whether the clinical diagnostic performance of the test reagent meets the requirements for auxiliary diagnosis of membranous nephropathy. Participants will provide approximately 4ml of blood. Researchers will compare the levels of anti-PLA2RIgG4 in patients with membranous nephropathy and patients with other renal diseases,to see if there is a significant difference.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05861869
Study type Observational
Source Zhejiang Biostar Biotechnology Co.
Contact
Status Enrolling by invitation
Phase
Start date May 4, 2023
Completion date June 2024